Source comparison
Comparison: Peptide Classes for Athletic Recovery
BPC-157 (Body Protection Compound) VEGF upregulation, GH receptor stabilization, collagen synthesis Tendon/ligament injuries, muscle tears, joint inflammation 4–8 weeks (localized injection or oral) Best-documented direct repair peptide. Human data limited but
This comparison does not assign a generated winner or score.
- BPC-157 (Body Protection Compound)
- VEGF upregulation, GH receptor stabilization, collagen synthesis
- Tendon/ligament injuries, muscle tears, joint inflammation
- 4–8 weeks (localized injection or oral)
- Best-documented direct repair peptide. Human data limited but animal studies show 30–50% faster healing across multiple tissue types
- TB-500 (Thymosin Beta-4 Fragment)
- Actin regulation, cell migration, inflammation suppression
- Acute muscle damage, chronic tendonitis, systemic recovery
- 2–6 weeks (subcutaneous injection)
- Strong anti-inflammatory profile. Athletes report faster soreness resolution and improved range of motion in injured joints
- CJC-1295 + Ipamorelin
- Pituitary GH release, IGF-1 production
- Systemic recovery, body composition, sleep quality
- 8–12 weeks (3–5x/week injection)
- Indirect recovery support through hormonal optimization. Not a 'fix' for acute injuries but valuable for managing training load long-term
- MK-677 (Ibutamoren, oral GH secretagogue)
- Ghrelin receptor agonist, sustained GH elevation
- Sleep enhancement, nitrogen retention, appetite regulation
- 12+ weeks (daily oral dose)
- Oral convenience vs injectable protocols. Useful for athletes needing prolonged GH support without frequent injections
- Comparing natural recovery peptides tested athletes use requires matching the injury type to the peptide's mechanism. A strained hamstring benefits more from BPC-157's localized repair signaling than from systemic GH elevation. Conversely, an athlete managing chronic overtraining symptoms. Elevated resting heart rate, poor sleep, stalled strength gains. Benefits more from CJC-1295/ipamorelin than from localized tissue repair agents.